Research Topic · Peer-Reviewed

Cardiovascular Disorders Cardiovascular Pharmacology

Cardiovascular disorders refer to any medical condition that affects the heart or the blood vessels. Fortunately, pharmaceutical science and technology have advanced significantly in their ability to treat and manage such disorders. The science of developing drugs that act on the cardiovascular system is known as ca…

Curated from this journal's research 📚 1 peer-reviewed article cited 🔖 ISSN 2328-0182 🗓 Reviewed June 2026

Overview

Cardiovascular disorders refer to any medical condition that affects the heart or the blood vessels. Fortunately, pharmaceutical science and technology have advanced significantly in their ability to treat and manage such disorders. The science of developing drugs that act on the cardiovascular system is known as cardiovascular pharmacology. The aim of cardiovascular pharmacology is to develop drugs that can treat or prevent cardiovascular disorders while minimizing adverse effects. The different classes of drugs used in cardiovascular pharmacology include beta-blockers, calcium channel blockers, and diuretics, among others. Beta-blockers act by blocking the effects of adrenaline on the heart and blood vessels, reducing the heart rate, and regulating blood pressure. Calcium channel blockers, on the other hand, block calcium flow into heart cells, thereby relaxing the blood vessels and reducing blood pressure. The development of newer drugs like Angiotensin-converting enzyme inhibitors (ACE inhibitors) and Angiotensin receptor blockers (ARBs) has significantly improved the management of cardiovascular disorders. These drugs act by blocking the actions of a hormone that narrows blood vessels, leading to an increase in blood pressure. Pharmaceutical science and technology have also advanced in the development of personalized medicine in cardiovascular pharmacology. Pharmacogenomics is used to study how genes affect a patient's response to a particular drug. The use of personalized medicine has proven to be more effective in the management of cardiovascular disorders in patients. In conclusion, the development of cardiovascular pharmacology has significantly impacted the management of cardiovascular disorders. The discovery of new drugs, the advancement of personalized medicine, and the use of pharmacogenomics have made it possible to tailor treatment for individual patients. With further advancements in pharmaceutical science and technology, we can expect even more effective drugs and treatments in the future.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

Editorial oversight

Curated from peer-reviewed research published in Advanced Pharmaceutical Science And Technology (ISSN 2328-0182).

Journal editorial board
natalia malara · Italy Saba Khalilpour · Italy Haseeb Khan · United States

This page summarises published research for orientation; it is not medical or professional advice.